Tag - SARS-CoV-2

Leading Health Providers Unite to Advance Patient Care by Forming Truveta

The Promise and Hope of RNA-based vaccines for COVID-19

Illumina and Helix Collaborate to Assess Prevalence of New SARS-CoV-2 UK Variant (B.1.1.7) in the US and Develop National Surveillance Infrastructure

2020 Was Not Just About COVID-19

UK Biobank launches one of the largest scientific studies measuring circulating proteins, to better understand the link between genetics and human disease

Thermo Fisher Scientific Announces Results of Offer to Acquire QIAGEN, Lapse of Offer and Termination of Acquisition Agreement

Helix Receives FDA Emergency Use Authorization for the HelixⓇ COVID-19 NGS Test, One of the First Sequencing-Based COVID-19 Tests

Sema4 Closes $121 Million Series C Led by BlackRock

Genomics England launches next-generation research platform central to UK COVID-19 response

Bluebee’s coherent data strategy set to unify Illumina’s data analytics products

DNAnexus Completes $100 Million Financing

QIAGEN launches new solution, QCI Interpret One, which combines QIAGEN Clinical Insights solutions with trusted N-of-One services to deliver gold-standard interpretation of somatic variants in cancer patients

Ginkgo Bioworks to Build Infrastructure for Rapid Epidemic Response with $70MM Investment

TruGenomix Partners with BlueBee to Create the Next Generation Behavioral Science Data Ecosystem

New partnership to sequence human genomes in the fight against coronavirus

COVID-19 / SARS-CoV-2

Copyright © 2026. enlighenbio LLC. All rights reserved.